From start-ups to leading global companies, Greater Fort Lauderdale provides a stimulating and supportive business environment for success in the life sciences.


Patient death in phase 3 raises doubts about safety of Roche’s potential hemophilia blockbuster emicizumab

VBL posts additional data from phase 2 thyroid cancer trial

Cancer player Nordic Nanovector stokes takeover talk

Roche won't sell diabetes business—it's looking for deals to boost it instead

Chutes & Ladders: Genentech oncology head jumps ship

Roche’s MS med Ocrevus delayed by, you guessed it, manufacturing issues

Roche to exit $75M diagnostics development deal with PacBio

Ophthotech’s anti-PDGF med fails late-stage combo tests in wet AMD